J. Biol. Chem., Vol. 261, Issue 27, 12513-12519, 09, 1986
Attenuation of sn-1,2-diacylglycerol second messengers. Metabolism of exogenous diacylglycerols by human platelets
WR Bishop and RM Bell
The metabolism of exogenous [3H]diacylglycerols by intact human platelets
was studied in order to examine: the metabolic fate of these second
messengers in an intact cell, the effect of diacylglycerol kinase and
diacylglycerol lipase inhibitors on this metabolism, the effect of agonist
stimulation on metabolism, and the dependence of metabolism on
diacylglycerol chain length. When 2.5 microM [3H]dioctanoylglycerol (diC8)
was added to 10(9) platelets it was rapidly metabolized; 80% was converted
to various products in 2.5 min. Initially, 40% was recovered as 3H-labeled
phospholipid (predominantly phosphatidic acid) reflecting the action of
diacylglycerol kinase, 20% was recovered as [3H]glycerol due to the action
of diacylglycerol and monoacylglycerol lipases, and small amounts were
recovered as triacylglycerol and monoacylglycerol. Thrombin stimulation of
platelets did not affect the rate or pathway of metabolism. Pretreatment of
platelets with the diacylglycerol kinase inhibitors, diC8ethyleneglycol or
1-monooleoylglycerol, inhibited 3H-labeled phospholipid production 47% and
75%, respectively, and resulted in a longer lived diC8 signal. The
diacylglycerol lipase inhibitor, RHC 80267, inhibited the production of
water-soluble metabolites 75%. Despite inhibition of the lipase, the
overall metabolism of exogenous [3H]diC8 occurred at a similar rate as in
control platelets due to an increased flux towards phospholipid. The
ability of exogenous diacylglycerols to be metabolized by diacylglycerol
kinase correlated well with their ability to activate protein kinase C in
platelets. [3H]Dibutyroylglycerol, didodecanoylglycerol, and
ditetradecanoylglycerol, were not metabolized by this route. These
diacylglycerols were still metabolized via the lipase pathway. The results
indicate that platelets possess potent attenuation systems to defend
against the accumulation of diacylglycerol second messengers, and that the
primary metabolic fate of cell-permeable, exogenous diacylglycerols is
conversion to phosphatidic acid.